What Is Pinealon? Brain Aging, Neuroprotection, and the Evidence
Summary
Host John Garrett analyzes pinealon, a three-amino acid peptide, distinguishing its promising cellular and animal data from limited human evidence. He critiques claims of neuroprotection and memory enhancement, noting that while lab studies show reduced oxidative stress, clinical trials are lacking. The episode emphasizes that pinealon is not FDA-approved and urges listeners to separate biological mechanisms from proven therapeutic benefits.
Topics discussed
Sponsor: The Peptide App
Introduction to Pinealon and Episode Goals
What is Pinealon? Composition and History
The Biological Problem: Brain Aging and Stress
Cellular Mechanisms: Oxidative Stress and DNA
60-Second Summary of Pinealon Research
Newer Human Cell Models and Induced Neurons
Animal Studies and Neuroprotection Signals
Human Evidence: Quality and Limitations
Subjective Reports and Attribution Challenges
Blood-Brain Barrier and Pharmacokinetics
Safety, Unknowns, and Alzheimer's Claims
Conclusion: Curiosity vs. Clinical Certainty
Listen ad-free on Castria